rs745517517
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001128227.3(GNE):c.268C>T(p.Arg90Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,458,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R90R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001128227.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNE | NM_001128227.3 | c.268C>T | p.Arg90Ter | stop_gained | 3/12 | ENST00000396594.8 | |
GNE | NM_005476.7 | c.175C>T | p.Arg59Ter | stop_gained | 3/12 | ENST00000642385.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNE | ENST00000396594.8 | c.268C>T | p.Arg90Ter | stop_gained | 3/12 | 1 | NM_001128227.3 | ||
GNE | ENST00000642385.2 | c.175C>T | p.Arg59Ter | stop_gained | 3/12 | NM_005476.7 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 exomes AF: 0.0000283 AC: 7AN: 247576Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134500
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1458630Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 725794
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
GNE myopathy Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 31, 2023 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Mar 02, 2015 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 10, 2020 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 24, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 12, 2016 | - - |
Sialuria;C1853926:GNE myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | May 21, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 285936). This variant has not been reported in the literature in individuals affected with GNE-related conditions. This variant is present in population databases (rs745517517, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Arg90*) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at